CAS: 939805-30-8
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | EOC317 REF: 54-BUP05608CAS: 939805-30-8 | 98% | 822.00 €~1,492.00 € | Mon 21 Apr 25 |
 | EOC317 REF: TM-T4318CAS: 939805-30-8 | 98.00% - 99.26% | 92.00 €~1,103.00 € | Thu 24 Apr 25 |
 | N-[4-[4-Amino-6-(methoxymethyl)-7-(4-morpholinylmethyl)pyrrolo[2,1-f][1,2,4]triazin-5-yl]-2-fluorophenyl]-N'-[2-fluoro-5-(trifluorom ethyl)phenyl]urea REF: 3D-FA104057CAS: 939805-30-8 | Min. 95% | - - - | Discontinued product |
Ref: 54-BUP05608
| 25mg | 822.00 € | ||
| 50mg | 1,174.00 € | ||
| 100mg | 1,492.00 € |
Estimated delivery in United States, on Monday 21 Apr 2025
EOC317
CAS:939805-30-8
EOC317 (ACTB-1003) is an oral kinase inhibitor (IC50: 6/2/4 nM, for FGFR1/VEGFR2/Tie-2).
Formula:
C27H26F5N7O3
Purity:
98.00% - 99.26%
Color and Shape:
Solid
Molecular weight:
591.53
Ref: TM-T4318
| 1mg | 92.00 € | ||
| 2mg | 135.00 € | ||
| 5mg | 188.00 € | ||
| 10mg | 329.00 € | ||
| 25mg | 560.00 € | ||
| 50mg | 800.00 € | ||
| 100mg | 1,103.00 € | ||
| 1mL*10mM (DMSO) | 255.00 € |
Estimated delivery in United States, on Thursday 24 Apr 2025
![N-[4-[4-Amino-6-(methoxymethyl)-7-(4-morpholinylmethyl)pyrrolo[2,1-f][1,2,4]triazin-5-yl]-2-fluoro…](https://static.cymitquimica.com/products/3D/thumb/FA104057.jpg)
N-[4-[4-Amino-6-(methoxymethyl)-7-(4-morpholinylmethyl)pyrrolo[2,1-f][1,2,4]triazin-5-yl]-2-fluorophenyl]-N'-[2-fluoro-5-(trifluorom ethyl)phenyl]urea
CAS:939805-30-8
Please enquire for more information about N-[4-[4-Amino-6-(methoxymethyl)-7-(4-morpholinylmethyl)pyrrolo[2,1-f][1,2,4]triazin-5-yl]-2-fluorophenyl]-N'-[2-fluoro-5-(trifluorom ethyl)phenyl]urea including the price, delivery time and more …
Formula:
C27H26F5N7O3
Purity:
Min. 95%
Molecular weight:
591.53 g/mol
Ref: 3D-FA104057
| 1mg | Discontinued | Request information | |
| 5mg | Discontinued | Request information | |
| 10mg | Discontinued | Request information |
